Project Details
Projekt Print View

Mansonella perstans effects on BCG vaccine-induced protection against childhood tuberculosis as well as tuberculosis disease severity and recovery in Ghana and Cameroon

Subject Area Parasitology and Biology of Tropical Infectious Disease Pathogens
Term from 2018 to 2023
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 405027271
 
Final Report Year 2024

Final Report Abstract

The MAP-TB project was based on the results from the MAP2-Co project, which focused on Mansonella perstans epidemiology, the role of Wolbachia endosymbionts and how M. perstans influence host immunity, especially the polarization of immune responses against mycobacterial infections (i.e. Buruli disease and tuberculosis). During the initial project, collaborations between the partner institutes from Germany (Bonn and Düsseldorf) and Africa (Cameroon and Ghana) have been established providing the basis for the MAP-TB project. The main objectives of the MAP-TB project were: i) to identify ecological and environmental characterisations for M. perstans vector abundance and transmission; ii) to decipher if M. perstans infections influence tuberculosis (TB) disease severity and time to recovery as well as Mycobacterium bovis Bacillus Calmette-Guérin (BCG) vaccination efficacy in children. Regarding the epidemiology objective, we revealed that dense equatorial rainforest is crucial for the transmission of M. perstans. Moreover, we identified Culicoides milnei as the major vector of M. perstans in Cameroon and Culicoides grahamii as the potential M. perstans vector in the middle belt region of Ghana. Based on these findings, we established an in vitro culture of M. perstans providing a platform for drug testing and assessment of the biology of this neglected filarial nematode. Furthermore, we obtained enough parasite material for complete mitochondrial genome sequencing of M. perstans and the establishment of an M. perstans-specific-loop mediated isothermal amplification (LAMP) assay which facilitated the detection of M. perstans infections in humans and vectors in the field. 144 patients with tuberculosis and 247 healthy adults and children/adolescents with contact to respective index cases were recruited in the Ashanti region of Ghana. Regarding parasite infections, the most prevalent was Plasmodium falciparum in 43 % of co-infected patients with tuberculosis, but unexpectedly only low numbers of participants (tuberculosis patients, n=2; contacts, n=1) had M. perstans infections. This observation prompted us to adapt the objectives of the MAP-TB project and we decided to investigate the impact of immunopathology in the peripheral blood of tuberculosis patients, the impact of parasite co-infection on tuberculosis and treatment efficacy, and the impact of BCG vaccination on M. tuberculosis infection-induced tuberculin skin test conversion in children/adolescents who are contacts of tuberculosis patients. We revealed a distinct immunopathology in a subset of patients with acute tuberculosis that was mediated by an inflammatory plasma cytokine milieu, the ameliorating effects of parasite co-infections on immunopathology and accelerated sputum conversion in co-infected patients during therapy; an impaired monocyte and T-cell cytokine expression in patients with tuberculosis, IL-6 as a biomarker candidate for detection of M. tuberculosis infection and a delayed tuberculin skin test (TST) conversion in BCG vaccinated child contacts of tuberculosis patients.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung